跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
李 婉若
主治醫師
,
衛生福利部雙和醫院
https://orcid.org/0000-0003-4659-3027
電子郵件
cmbwrlee
tmu.edu
tw
h-index
5053
引文
38
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
1991 …
2023
每年研究成果
概覽
指紋
網路
專案
(11)
研究成果
(135)
資料集
(2)
類似的個人檔案
(6)
如果您對這些純文本內容做了任何改變,很快就會看到。
指紋
查看啟用 Woan-Ruoh Lee 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine & Life Sciences
Lasers
100%
Solid-State Lasers
99%
Skin
99%
Cellular Apoptosis Susceptibility Protein
59%
Erbium
48%
Melanoma
34%
Nitric Oxide
30%
Psoriasis
27%
Keloid
26%
Apoptosis
26%
Pharmaceutical Preparations
26%
Skin Absorption
26%
Chromosome Segregation
25%
Neoplasms
25%
wogonin
24%
Reactive Oxygen Species
24%
Quercetin
23%
Small Interfering RNA
23%
Aminolevulinic Acid
23%
Colorectal Neoplasms
20%
Dinoprostone
20%
Cornea
20%
Nitric Oxide Synthase Type II
19%
Gas Lasers
19%
Caspase 3
18%
Taiwan
18%
Lipopolysaccharides
17%
In Vitro Techniques
17%
fisetin
16%
Atopic Dermatitis
16%
Nanoparticles
15%
Proteins
15%
HL-60 Cells
15%
Rutin
15%
Sinus Histiocytosis
15%
HIV-1
14%
Epidermis
14%
Imiquimod
14%
Confocal Microscopy
14%
Peptides
13%
Chronic Urticaria
13%
Neoplasm Metastasis
12%
Therapeutics
12%
Extracellular Signal-Regulated MAP Kinases
12%
Cyclooxygenase 2
12%
Electroporation
12%
Fluorouracil
12%
Nevus
11%
Dermatology
11%
quercetin pentaacetate
11%
Chemical Compounds
Erbium
76%
Nitric Oxide
31%
Imiquimod
31%
Drug
30%
Protein
28%
Macromolecule
27%
Ablation
26%
5-Aminolevulinic Acid
20%
Dextran
18%
Silencing RNA
18%
Collagen
18%
Prostaglandin E2
17%
Peptide
16%
Wogonin
16%
Transdermal
16%
Quercetin
16%
Reactive Oxygen Metabolite
15%
Small Interfering RNA
15%
Lipopolysaccharide
13%
Confocal Laser Scanning Microscopy
13%
Folic Acid
11%
Imatinib
11%
Confocal Microscopy
11%
Dioxygen
9%
Percutaneous
9%
Second-Harmonic Generation
9%
Nanoparticle
9%
Liposome
9%
Protoporphyrin
9%
Vemurafenib
9%
Nilotinib
8%
Peroxide
8%
Fluorescein Isothiocyanate
8%
Andrographolide
7%
Sorafenib
7%
Apoptotic
7%
Sunscreening Agent
7%
Nitric Oxide Synthase Inhibitor
7%
Rutin
7%
Permeability
7%
Emodin
7%
Erythropoietin
7%
5-Fluorouracil
7%
Flavanone
7%
Antisense Oligonucleotide
7%
Flavanones
6%
Western Blotting
6%
Safety
6%